Transforming Health

with Cutting-

Edge

Biopharma

Solutions

Our products are being developed for and are intended to treat complex diseases and unmet medical needs including Ischemia and Hypoxia Within Stroke, Sickle Cell Disease, and Cystic Fibrosis

discover our product

Prolong
Pharmaceuticals

Prolong Pharmaceuticals

Meeting critical
unmet medical needs.

We are a clinical-stage biopharma leader developing innovative treatments for CNS, Hematology, and Respiratory Disorders.

about us
Our Team

Innovative Leaders in Biotech

Our leadership team has driven success in multiple pharmaceutical and biotechnology companies. Prolong’s founders invented PEGylation, a breakthrough drug delivery technology responsible for many life-improving drugs for hepatitis, kidney disease, and other severe conditions.

meet the team

How does Sanguinate® work?

Learn how you can be part of the journey

Join us in revolutionizing treatments for severe and life-threatening conditions
contact us
Prolong’s Critical Role in Combating Stroke

Addressing a Worldwide Health Issue

55M
People suffer a stroke each year
5M
Deaths each year from stroke
700k
Patients eligible for treatment
learn more

Learn how you can be part of the journey

Join us in revolutionizing treatments for severe
and life-threatening conditions